Page 6 - Mark Augusti News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Conformis, Inc. to Present at the Canaccord Genuity Musculoskeletal Conference May 12, 2021 18:10 ET | Source: Conformis, Inc. Conformis, Inc. Billerica, Massachusetts, UNITED STATES BILLERICA, Mass., May 12, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will present at the Canaccord Genuity Musculoskeletal Conference. The virtual presentati...

Top Penny Stocks to Watch With Important Announcements With May well underway, penny stocks are very much still in focus. But, several industries are seeing more attention than others. Right now, this includes biotech stocks, blockchain stocks, and others. While penny stocks do trade off of fundamentals, usually speculative factors can have a greater impact. This is something that simply comes with the territory.  Now, the large effect of speculation on certain penny stocks to buy, means that investors need to watch the market intently and regularly. While not all traders use a swing trad...

Message : Required fields BILLERICA, Mass., April 07, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the first quarter ended March 31, 2021 after the market closes on May 5, 2021 at approximately 4:00 p.m. Eastern Time. Mark Augusti, CEO, and Bob Howe, CFO, will host a webcast and conference call also on Wednesday, May 5, 2021, at 4:30 p.m. Eastern Time to discuss the financial results and to provide a business update. To attend by telephone, please use the information below for dial-in access.   When prompted on dia...

(2) Independent, retrospective review of 2016-2019 surgeon data by University of Washington researchers demonstrates that Conformis iTotal knee replacement implants enable expedited surgical time and reduce length of hospital stay. BILLERICA, Mass., March 17, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that an independent, retrospective review of hospital data has concluded that Conformis iTotal knee replacement technology is more cost-effective than leading traditional, off-the-shelf implants. Importantly, this study was independently performed with no sponsorshi...

CFMS Stock: Why Under-the-Radar Conformis Is on the Move InvestorPlace 3/2/2021 Shares of medtech Conformis (NASDAQ: CFMS) surged more than 17% in pre-market trading on Tuesday after the company said it had received clearance in Australia for its total knee replacement system. CFMS stock has touched a 52-week high price of $1.48 per share twice since January. © Provided by InvestorPlace surgeons operating on a patient The patient-specific iTotal PS total knee replacement system, which was launched in the U.S. in 2016, got a green light for use down under by the Therapeutic Goods Adminis...